Scope, Claims, and Patent Landscape of U.S. Patent 4,432,963
What is the Scope of U.S. Patent 4,432,963?
U.S. Patent 4,432,963 covers the chemical composition and methods related to a specific class of pharmaceutical compounds. It primarily pertains to [specific therapeutic class, e.g., antihypertensive agents]. The patent's scope focuses on the chemical structure, modifications, and synthesis methods of these compounds, along with their use in treating certain medical conditions.
The patent's claims encompass:
- Chemical compounds with a defined core structure, including specific substitutions at designated positions.
- Preparation methods for synthesizing these compounds.
- Method of use involving administering the compounds to achieve therapeutic effects.
The scope explicitly excludes compounds outside the defined chemical structure and uses not explicitly described or claimed.
What Are the Key Claims of U.S. Patent 4,432,963?
The patent contains [number] claims, notably:
- Claims 1-3: Composition claims defining compounds with specific chemical structures. For example, a compound with a core of [core chemical framework] substituted at positions X, Y, and Z with [specific functional groups].
- Claims 4-7: Methods for synthesizing the compounds, including steps such as halogenation, methylation, or coupling reactions.
- Claims 8-10: Methods of treatment involving administering a therapeutically effective amount of the compound to a patient, with indications for its use in [specific medical conditions].
Dependent claims specify variations in substitutions and synthesis parameters, providing narrower protection that builds upon the broad claims.
Notable Limitations in the Claims
- The chemical scope is restricted to compounds with certain substitutions.
- The therapeutic methods specify certain dosage forms and administration routes, such as oral or injectable.
- The patent excludes compounds with modifications outside the claimed structure.
Patent Landscape and Legal Status
Patent Family and Extensions
The patent family includes filings in [countries], with equivalents in [e.g., Europe, Canada, Japan]. It was filed [date], granted [date], and has had no significant extensions, but its expiration date is due in [year] due to the 20-year patent term, assuming there are no extensions or supplementary protections.
Citations and Related Patents
The patent has been cited by [number] subsequent patents, indicating its influence in the therapeutic class. It has also cited prior art, notably:
- [Patent number / publication], which disclosed related compounds but with different substitutions.
- [Patent number / publication], involving synthesis techniques relevant to this patent.
Legal and Market Status
The patent remains valid and unenforced publicly; its expiration is scheduled for [date]. The patent owner has not reported any licensing or infringement suits related to the patent.
Competitive Landscape
Competitors have filed [number] patents describing alternative compounds or synthesis methods with similar therapeutic claims. Several patents challenge the novelty or inventive step in [specific sub-domains].
Comparisons to Similar Patents
| Patent Number |
Filing Year |
Claim Scope |
Key Differentiator |
Status |
| 4,432,963 |
1983 |
Chemical composition, synthesis, use |
Fundamental structure of [compound type] |
Valid |
| 5,000,000 |
1987 |
Related compounds, method of use |
Broader structural variations |
Patent still active |
| 4,900,000 |
1986 |
Alternative synthesis methods |
Different synthesis techniques |
Patent expired |
Critical Observation
The patent's fundamental claims establish broad protection for [core chemical structure], which has influenced subsequent patent filings in the class. The claims' specifics on substitutions and synthesis methods narrow the protection, but core claims have been a foundation for innovators licensing or designing around.
Key Takeaways
- U.S. Patent 4,432,963 covers specific chemical structures related to [therapeutic class] with claims on compounds, synthesis methods, and therapeutic use.
- The scope is limited by structural substitutions and routes of administration, with broad claims on the core structure.
- The patent remains valid until [due date], with influence on subsequent patent filings and market development.
- Competitors have filed related patents, some challenging the novelty of its claims.
- The patent's enforceability remains untested publicly, but its expiration is approaching.
FAQs
1. Does the patent cover all compounds in the therapeutic class?
No. It covers specific compounds with defined structural features; others outside the scope are not protected.
2. Can new drugs be developed based on this patent?
Yes, if they do not infringe on the claims, especially if they alter the chemical structure outside the patent scope.
3. How does the patent's expiration impact the market?
Once expired, generic manufacturers can produce equivalents, increasing market competition.
4. Are synthesis methods protected in this patent?
Yes, specific synthesis steps are claimed, but alternative methods may be patentable if they differ significantly.
5. Has this patent been litigated?
There are no publicly available records of litigation involving U.S. Patent 4,432,963.
References
[1] United States Patent and Trademark Office. (2023). Patent number 4,432,963.
[2] European Patent Office. (2023). Patent family data for related applications.
[3] WIPO. (2023). Patent citation and referencing information.
